Serdar Bulun

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This biography of a living person needs additional citations for verification, as its only attribution is to self-published sources; articles should not be based solely on such sources. Please help by adding reliable, independent sources. Immediately remove contentious material about living people that is unsourced or poorly sourced. (January 2016) (Learn how and when to remove this message) A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (January 2016) (Learn how and when to remove this message) (Learn how and when to remove this message)

Serdar Bulun is a gynecologist, with a special interest in the common gynecologic diseases, endometriosis and uterine fibroids.^{[1][2][3][4][5]}

Bulun was born in Malatya, Turkey in 1959 and moved to Istanbul to attend Robert College and thereafter Istanbul University School of Medicine (Çapa Tıp Fakültesi). He completed his residency in obstetrics and gynecology at the University at Buffalo in New York and pursued a sub-specialty fellowship in reproductive endocrinology-infertility at the University of Texas Southwestern Medical Center at Dallas. Starting from 2003, he established a comprehensive women’s health research program at Northwestern, and recruited and supported numerous faculty who focus on steroid hormone-related pathology of uterine, breast and ovarian disorders.^[6] Throughout his career, Dr. Bulun has been awarded over $70 million of research funding in endometriosis, uterine fibroids and breast cancer.^{[3][4][5][6][7][8][9][10][11][12]}

Bulun discovered the epigenetic basis of endometriosis leading to progesterone resistance in this disease, and introduced aromatase inhibitors as a novel class of drugs to treat it.^{[1][3][5][11]} His team isolated tumor stem cells from uterine fibroids and targeted these to treat this disease.^{[2][4][6][10]} His team discovered the first set of gain-of-function mutations affecting the aromatase gene leading to breast development and estrogen excess in prepubertal humans and contributed to the genetics and systems biology aspects of hormone-responsive disorders of the breast, including cancer.^{[7][8][9][12]}

Bulun is the editor-in-chief of Seminars in Reproductive Medicine.^[13] He has been elected to the National Academy of Medicine (formerly known as the Institute of Medicine), the Association of American Physicians and the American Society for Clinical Investigation.^[14][15][16] He served as the 2015 president for the Society for Reproductive Investigation.^[17] He has received the National Institutes of Health-MERIT award for his work in endometriosis and the American Society of Reproductive Medicine Distinguished Researcher Award.^[18][19]

• National Academy of Medicine (formerly Institute of Medicine, IOM, elected 2015)^[14]
• John J. Sciarra Professor of Obstetrics and Gynecology, Northwestern University (2012–present)^[20]
• Association of American Physicians (AAP, elected 2012)^[16]
• American Society for Reproductive Medicine (ASRM) Distinguished Researcher Award (2012)^[19]
• National Institutes of Health MERIT (R37) Award HD38691 (2010-2020)^[18]
• George H. Gardner Professor of Clinical Gynecology, Northwestern University (2006-2012)^[21]
• American Society for Clinical Investigation (ASCI, elected 2003)^[15]